Biora Therapeutics (NASDAQ:BIOR) Trading 41.7% Higher – Should You Buy?

Biora Therapeutics, Inc. (NASDAQ:BIOR)’s stock price traded up 41.7% during mid-day trading on Tuesday . The stock traded as high as $0.18 and last traded at $0.17. 89,158 shares traded hands during trading, an increase of 53% from the average session volume of 58,319 shares. The stock had previously closed at $0.12.

Analyst Upgrades and Downgrades

Separately, HC Wainwright upped their price objective on Biora Therapeutics from $15.00 to $23.00 and gave the stock a “buy” rating in a report on Monday, November 18th.

Biora Therapeutics Trading Up 41.7 %

The firm has a fifty day simple moving average of $0.22 and a 200-day simple moving average of $2.90. The stock has a market cap of $768,910.00, a price-to-earnings ratio of -0.01 and a beta of 1.12.

About Biora Therapeutics

Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.